[Interferon treatment for aged patients with hepatitis C].
Hiramatsu
Naoki
N
Department of Gastroenterology, Osaka University School of Medicine.
Kasahara
Akinori
A
Hayashi
Norio
N
Imai
Yasuharu
Y
D000367:Age Factors; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005355:Fibrosis; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D007372:Interferons / Q000008:administration & dosage*; D008113:Liver Neoplasms / Q000209:etiology / Q000517:prevention & control; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011379:Prognosis; D012307:Risk Factors; D012737:Sex Factors
D007372:Interferons